Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress

FEBS Letters

Volumn 583, Issue 4, 2009, Pages 648-654

  Jeong, Eui Man ^a   Kim, Chai Wan ^a   Cho, Sung Yup ^a   Jang, Gi Yong ^a   Shin, Dong Myung ^a   Jeon, Ju Hong ^a   Kim, In Gyu ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Calcium overload; Oxidative stress; Proteasomal degradation; Transglutaminase 2; Ubiquitination

Indexed keywords

CALCIMYCIN; CALCIUM; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UBIQUITINATION;

ADENOVIRIDAE; ANTI-BACTERIAL AGENTS; APOPTOSIS; CALCIMYCIN; CALCIUM; CELL DEATH; CELL LINE; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GTP-BINDING PROTEINS; HELA CELLS; HUMANS; KIDNEY; LEUPEPTINS; OXIDATIVE STRESS; TIME FACTORS; TRANSGLUTAMINASES; UBIQUITINATION;

EID: 60049098220     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.01.032     Document Type: Article

References (28)

1. Lorand L., and Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 4 (2003) 140-156
2. Fesus L., and Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27 (2002) 534-539
3. Fesus L., Thomazy V., and Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224 (1987) 104-108
4. Fesus L., and Szondy Z. Transglutaminase 2 in the balance of cell death and survival. FEBS Lett. 579 (2005) 3297-3302
5. De Laurenzi V., and Melino G. Gene disruption of tissue transglutaminase. Mol. Cell Biol. 21 (2001) 148-155
6. Herman J.F., Mangala L.S., and Mehta K. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 25 (2006) 3049-3058
7. Han J.A., and Park S.C. Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line. J. Cancer Res. Clin. Oncol. 125 (1999) 89-95
8. Shin D.M., et al. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J. Biol. Chem. 279 (2004) 15032-15039
9. Shin D.M., et al. TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation. Faseb J. 22 (2008) 2498-2507
10. Lai T.S., Slaughter T.F., Peoples K.A., Hettasch J.M., and Greenberg C.S. Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J. Biol. Chem. 273 (1998) 1776-1781
11. Liu S., Cerione R.A., and Clardy J. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc. Natl. Acad. Sci. USA 99 (2002) 2743-2747
12. Pinkas D.M., Strop P., Brunger A.T., and Khosla C. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 5 (2007) e327
13. Begg G.E., Holman S.R., Stokes P.H., Matthews J.M., Graham R.M., and Iismaa S.E. Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity. J. Biol. Chem. 281 (2006) 12603-12609
14. Fabbi M., Marimpietri D., Martini S., Brancolini C., Amoresano A., Scaloni A., Bargellesi A., and Cosulich E. Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation. Cell Death Differ. 6 (1999) 992-1001
15. Jeon J.H., et al. Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine. Embo J. 22 (2003) 5273-5282
16. Tang E.H., Leung F.P., Huang Y., Feletou M., So K.F., Man R.Y., and Vanhoutte P.M. Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br. J. Pharmacol. 151 (2007) 15-23
17. Naora H., and Naora H. Differential expression patterns of beta-actin mRNA in cells undergoing apoptosis. Biochem. Biophys. Res. Commun. 211 (1995) 491-496
18. Cohly H., Jenkins J., Skelton T., Meydrech E., and Markov A.K. Fructose-1,6-diphosphate suppresses T-lymphocyte proliferation, promotes apoptosis and inhibits interleukins-1,6, beta-actin mRNAs, and transcription factors expression. Immunol. Invest. 33 (2004) 407-421
19. Muller C.S., Huff T., and Hannappel E. Reduction of thymosin beta4 and actin in HL60 cells during apoptosis is preceded by a decrease of their mRNAs. Mol. Cell Biochem. 250 (2003) 179-188
20. Zhang J., Guttmann R.P., and Johnson G.V. Tissue transglutaminase is an in situ substrate of calpain: regulation of activity. J. Neurochem. 71 (1998) 240-247
21. Antonyak M.A., Singh U.S., Lee D.A., Boehm J.E., Combs C., Zgola M.M., Page R.L., and Cerione R.A. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J. Biol. Chem. 276 (2001) 33582-33587
22. Antonyak M.A., Miller A.M., Jansen J.M., Boehm J.E., Balkman C.E., Wakshlag J.J., Page R.L., and Cerione R.A. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J. Biol. Chem. 279 (2004) 41461-41467
23. Fesus L., and Tarcsa E. Formation of N epsilon-(gamma-glutamyl)-lysine isodipeptide in Chinese-hamster ovary cells. Biochem. J. 263 (1989) 843-848
24. Sarang Z., et al. Tissue transglutaminase (TG2) facilitates phosphatidylserine exposure and calpain activity in calcium-induced death of erythrocytes. Cell Death Differ. 14 (2007) 1842-1844
25. 2+ spiking to cell cycle progression. Reproduction 130 (2005) 813-823
26. Allaman-Pillet N., et al. Calcium- and proteasome-dependent degradation of the JNK scaffold protein islet-brain 1. J. Biol. Chem. 278 (2003) 48720-48726
27. Shen C., Ye Y., Robertson S.E., Lau A.W., Mak D.O., and Chou M.M. Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. J. Biol. Chem. 280 (2005) 35967-35973
28. Esposito C., Marra M., Giuberti G., D'Alessandro A.M., Porta R., Cozzolino A., Caraglia M., and Abbruzzese A. Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells. Biochem. J. 370 (2003) 205-212